Scientist Jarrett Bilton, PhD, recently travelled to the 25th North American ISSX conference in Boston. In collaboration with researchers at Genentech, RepliGut® Planar Jejunum was evaluated for gene expression patterns. The focus was on understanding how RepliGut Planar Jejunum responds to prototypical metabolic inducers Rifampin, CITCO, 3-MC, and Calcitriol. The poster shows the suitability of RepliGut® Planar Jejunum. It is used for studying the contribution of intestinal epithelial cells. These cells play a significant role in drug-drug interactions.
Poster: Genomic evaluation of RepliGut Planar Jejunum in Response to metabolic Inducers
Ready to design your study?
Why GI Toxicity Slips Through Preclinical Screening
Ask a program lead which toxicity they are most afraid of finding late, and the gut is rarely the first…
Well-to-Well Consistency: Seeding, Confluence, and Real Signal vs Noise
Some of the most damaging variability in a gut assay never involves the drug at all. It lives between neighboring…
Reproducibility in Your Hands: Why an Assay Drifts When It Moves Between Labs
A model can be perfectly reproducible in the lab that built it and still fall apart the moment it lands…